FDA Updates Guidance for Homeopathic Drugs; Increased Scrutiny for Certain Categories of Products Posted: 21 Dec 2017 11:53 PM PST By Riëtte van Laack —

http://www.fdalawblog.net/2017/12/fda-updates-guidance-for-homeopathic-drugs-increased-scrutiny-for-certain-categories-of-products/?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+FdaLawBlog+%28FDA+Law+Blog%29

FDA Chief Says He’s Open To Rethinking Incentives On Orphan Drugs

https://khn.org/news/fda-chief-says-hes-open-to-rethinking-incentives-on-orphan-drugs/

U.S. life expectancy falls for second straight year — as drug overdoses soar

https://www.msn.com/en-us/news/us/us-life-expectancy-falls-for-second-straight-year-—-as-drug-overdoses-soar/ar-BBH6f40?li=AA4ZnC&ocid=spartandhp

High Importance!! Primus Pharmaceuticals, Inc. FDA Requested Recall Letter

Importance

12/18/2017

3006052875

Primus Pharmaceuticals, Inc.

FDA Requested Recall Letter

AZ

12/19/2017

Sound policy, more transparency can help companies fight opioid ...

Jackson County Newspapers-18 hours ago

Given that distributors like us are responsible for helping to deliver safely physician-prescribed medications to pharmacies, we have a unique perspective into how this supply chain works — and the ways it can be subverted by bad actors. This is why I know that what would be most effective would be better collaboration, ...

Community pharmacy: plans for the new year

Australian Journal of Pharmacy (blog)-21 hours ago

The recent pharmacy Barometer found that community pharmacy is slightly more positive than a year ago, but owners and staff are still concerned about challenges they face to secure their future, explains Mr Quilty. “Pharmacy owners and staff see the future of 

$515 million sale of local pharmacy benefits firm wraps up

St. Louis Business Journal-9 hours ago

Diplomat Pharmacy Inc. has closed on its acquisition of St. Louis-based LDI Integrated Pharmacy Services for $515 million in cash and about $80 million in Diplomat stock. Flint, Michigan-based Diplomat bought LDI, a pharmacy benefit management firm, from investment firms Nautic Partners LLC and Oak HC/FT Partners ...

India pharma exports to touch $20 bln by 2020: study

Business Standard-14 hours ago

Indian pharmaceutical exports are likely to touch $20 billion by 2020 from the current level of around $16.5 billion, registering a compounded annual growth rate (CAGR) ... India is the third-largest global generic Active Pharmaceutical Ingredient (API) manufacturer in terms of market share and generic drugs form the largest ...

Compounders Who Skirt The FDA: Who Is The Expert Here?

Compounders Who Skirt The FDA: Who Is The Expert Here?

The National Law Review-6 hours ago

Is it true? According to Allergen, it's not. The statement in question is a claim made for a compounded drug. These drugs are not fully tested and approved by the FDA, combine active ingredients with FDA-approved drugs, and then claim superiority to them. Now it sits in the form of two lawsuits filed in California by Allergen 

United States: FDA 2017 Year In Review: Therapeutic Products, Part 2

Mondaq News Alerts-8 hours ago

As alluded to above, FDA inspections of traditional compounders and outsourcing facilities continue be very high priority as the Agency seeks to reform the drug compounding industry under the congressional mandate that is the DQSA. Compliance Director Ashley's year-end presentation (see above) reported that, ...